Always fresh Renobrain SM (polypeptides of cattle cerebral cortex) 10 vials
Active substance polypeptides of cattle cerebral cortex:
cattle cerebral cortex polypeptides
Pharmacotherapy group Renobrain SM:
nootropic agent
Drug form
Renobrein® CM
Administration 10 mg lyophilisate substituted r/o/m: fl. 10
Lyophilizate for preparing an I/M infusion solution in the form of a tablet, whole, partially or completely cut, white or white with a yellowish tint of color; the reduced solution is transparent and colorless or yellowish in color.
1 fl.
water-soluble polypeptide fraction complex* produced from the cerebral cortex of cattle 10 mg
* with a molecular mass not exceeding 10,000 Da.
Auxiliary substances: glycine - 12 mg.
Drug form polypeptides of cattle cerebral cortex
Renobrein® CM
Administration 10 mg lyophilisate substituted r/o/m: fl. 10
Lyophilizate for preparing an I/M infusion solution in the form of a tablet, whole, partially or completely cut, white or white with a yellowish tint of color; the reduced solution is transparent and colorless or yellowish in color.
1 fl.
water-soluble polypeptide fraction complex* produced from the cerebral cortex of cattle 10 mg
* with a molecular mass not exceeding 10,000 Da.
Auxiliary substances: glycine - 12 mg.
Indications Renobrain SM:
Comprehensive therapy is used to treat various cerebrovascular and traumatic brain injury disorders and their consequences.
This technique aids in the fight against encephalopathy of various origins, cognitive disorders, acute and chronic encephalitis and encephalomyelitis, epilepsy, asthenic state and reduced ability to learn. It is also effective in delaying children's psychomotor and speech development and various forms of cerebral palsy.
Method of application Renobrain SM:
The drug is injected into the person's muscles. The contents of the vial should be dissolved in 1 to 2 mL of procaine (0.5%), water for injection, or sodium chloride (0.9%) before injection. When dissolving, aim the needle against the bottle wall to avoid foaming. It is given to adults once a day at a dose of 10 mg of the active ingredient for 10 days. The dose is 0.5 mg of active ingredient per kg for children under 20 kg and 10 mg for 10 days for those over 20 kg. If necessary, treatment can be repeated in 3 to 6 months. For acute and early recovery hemispheric ischemic stroke, adults are advised to give 10 mg twice daily (morning and afternoon) of the active ingredient for 10 days, followed by a second course 10 days later.
- ICD-10 Renobrain SM Code Indication
- F06.7 Mild cognitive disorder
- F45.3 Somatoform autonomic dysfunction
- F80.8 Other developmental disorders of speech and language
- F81.9 Developmental learning disorder, unspecified
- G04 Encephalitis, myelitis, and encephalomyelitis
- G40 Epilepsy
- G80 Cerebral palsy
- G93.4 Encephalopathy unspecified
- I67.9 Cerebrovascular disease, unspecified
- R25.2 Cramp and spasm
- R53 Malaise and fatigue
- S06 Intracranial injury